436 related articles for article (PubMed ID: 2858911)
21. [Prevention of cerebrovascular circulatory disorders].
Herrschaft H
Fortschr Neurol Psychiatr; 1985 Sep; 53(9):337-43. PubMed ID: 4043914
[TBL] [Abstract][Full Text] [Related]
22. [Metabolic risks of oral contraception].
Monier L
Rev Int Pediatr; 1988 Feb; (178):64-5. PubMed ID: 12282576
[TBL] [Abstract][Full Text] [Related]
23. [Therapy and prevention of coronary heart diseases through lowering of the serum cholesterol levels; third consensus 'Cholesterol'. Consensus Working Group, CBO].
Simoons ML; Casparie AF
Ned Tijdschr Geneeskd; 1998 Sep; 142(38):2096-101. PubMed ID: 9856223
[TBL] [Abstract][Full Text] [Related]
24. [Impact of primary and secondary prevention on morbidity and mortality of ischemic cardiopathy].
Posadas-Romero C
Arch Cardiol Mex; 2002; 72 Suppl 1():S167-70. PubMed ID: 12001839
[TBL] [Abstract][Full Text] [Related]
25. Diet and lifestyle guidelines and desirable levels of risk factors for the prevention of diabetes and its vascular complications in Indians: a scientific statement of The International College of Nutrition. Indian Consensus Group for the Prevention of Diabetes.
Singh RB; Rastogi SS; Rao PV; Das S; Madhu SV; Das AK; Sahay BK; Fuse SM; Beegom R; Sainani GS; Shah NA
J Cardiovasc Risk; 1997 Jun; 4(3):201-8. PubMed ID: 9475675
[TBL] [Abstract][Full Text] [Related]
26. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.
Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ
Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012
[TBL] [Abstract][Full Text] [Related]
27. [Oral contraception and carbohydrate metabolism: III--practical implications].
Hilal M
Contracept Fertil Sex (Paris); 1986 Jan; 14(1):59-62. PubMed ID: 12341242
[TBL] [Abstract][Full Text] [Related]
28. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
29. Treatment of metabolic syndrome.
Wagh A; Stone NJ
Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
[TBL] [Abstract][Full Text] [Related]
30. The future of antihypertensive treatment.
Israili ZH; Hernández-Hernández R; Valasco M
Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
[TBL] [Abstract][Full Text] [Related]
31. Changes in secondary prevention of coronary artery disease in the post-discharge period over the decade 1997-2007. Results of the Cracovian Program for Secondary Prevention of Ischaemic Heart Disease and Polish parts of the EUROASPIRE II and III surveys.
Pajak A; Jankowski P; Kawecka-Jaszcz K; Surowiec S; Wolfshaut R; Loster M; Batko K; Badacz L; Dubiel JS; Grodecki J; Grodzicki T; Maciejewicz J; Mirek-Bryniarska E; Piotrowski W; Smielak-Korombel W; Tracz W
Kardiol Pol; 2009 Dec; 67(12):1353-9. PubMed ID: 20054766
[TBL] [Abstract][Full Text] [Related]
32. [Cardiovascular risks of oral contraceptives: dose-response relationship].
Kelleher CC
Contracept Fertil Sex (Paris); 1991 Apr; 19(4):285-8. PubMed ID: 12343220
[TBL] [Abstract][Full Text] [Related]
33. Secondary prevention of coronary heart disease in elderly patients.
Hanna IR; Wenger NK
Am Fam Physician; 2005 Jun; 71(12):2289-96. PubMed ID: 15999866
[TBL] [Abstract][Full Text] [Related]
34. The recognition and management of hyperlipidaemia in adults: A policy statement of the European Atherosclerosis Society.
Eur Heart J; 1988 May; 9(5):571-600. PubMed ID: 3402474
[TBL] [Abstract][Full Text] [Related]
35. Blood viscosity and thrombosis: clinical considerations.
Smith BD; La Celle PL
Prog Hemost Thromb; 1982; 6():179-201. PubMed ID: 6762612
[TBL] [Abstract][Full Text] [Related]
36. Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.
Weber M; McNicoll S; Marcil M; Connelly P; Lussier-Cacan S; Davignon J; Latour Y; Genest J
Can J Cardiol; 1997 Mar; 13(3):253-60. PubMed ID: 9117913
[TBL] [Abstract][Full Text] [Related]
37. Lifestyle modifications to prevent and control hypertension. 5. Recommendations on dietary salt. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.
Fodor JG; Whitmore B; Leenen F; Larochelle P
CMAJ; 1999 May; 160(9 Suppl):S29-34. PubMed ID: 10333851
[TBL] [Abstract][Full Text] [Related]
38. Primary and secondary prevention.
Wilhelmsen L
J Hypertens Suppl; 1987 Aug; 5(3):S79-82. PubMed ID: 3478430
[TBL] [Abstract][Full Text] [Related]
39. Stroke prevention: management of modifiable vascular risk factors.
Leys D; Deplanque D; Mounier-Vehier C; Mackowiak-Cordoliani MA; Lucas C; Bordet R
J Neurol; 2002 May; 249(5):507-17. PubMed ID: 12021938
[TBL] [Abstract][Full Text] [Related]
40. [Secondary prevention in acute myocardial infarction].
Ferreira R; Ferreira D; Correia MJ; De Sá ME; De Sousa JV; Sousa JV; Tavares MG
Acta Med Port; 2001; 14(2):149-69. PubMed ID: 11475986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
